Law360, New York (October 25, 2011, 11:54 AM ET) -- Private equity firm Metalmark Capital Holdings LLC acquired a majority stake in Bostwick Laboratories Inc., a urology-focused laboratory services provider, to expand the company's work in monitoring and diagnosing diseases such as prostate cancer, Bostwick said Tuesday.
Bostwick's founder and CEO David G. Bostwick will remain a major shareholder in the laboratories, the company said in a statement. The parties did not disclose terms of the deal and did not immediately respond to request for comment Tuesday.
“This investment will provide the capital we need to pursue our...
Ropes Helps Metalmark In Bostwick Labs Takeover
To view the full article, take a free trial now.
